Risk Factors for Asparaginase-associated Pancreatitis: A Systematic Review

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Clinical Gastroenterology

• Publication date

  2017-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MCG.0000000000000827PMID 28375864PMCID PMC11488675
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Crisis management in the treatment of childhood acute lymphoblastic leukemia: putting right what can go wrong (emergency complications of disease and treatment).

  2017cited by this paper
• Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus.

  2016cited by this paper
• A prognostic tool to predict severe acute pancreatitis in pediatrics.

  2016cited by this paper
• Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.

  2016cited by this paper
• Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.

  2015cited by this paper
• Relationship Between Modified CT Severity Index and Clinical Features of L-Asparaginase-Associated Pancreatitis in Pediatric Acute Lymphoblastic Leukemia

  2014cited by this paper
• Asparaginase‐associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol

  2014cited by this paper
• Incidence and outcome of pancreatitis in children and young adults with acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003

  2013cited by this paper
• Complications of endoscopic retrograde cholangiopancreatography: avoidance and management.

  2012cited by this paper
• Asparaginase‐associated pancreatitis in children

  2012cited by this paper
• Definitions of Pediatric Pancreatitis and Survey of Present Clinical Practices

  2012cited by this paper
• Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus

  2012cited by this paper
• Polyethylene Glycol-conjugated L-asparaginase Versus Native L-asparaginase in Combination With Standard Agents for Children With Acute Lymphoblastic Leukemia in Second Bone Marrow Relapse: A Children's Oncology Group Study (POG 8866)

  2011cited by this paper
• What Have We Learned About Acute Pancreatitis in Children?

  2011cited by this paper
• Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia.

  2010cited by this paper
• Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia

  2010cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

  2009cited by this paper
• Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase‐associated pancreatitis

  2009cited by this paper
• Acute Pancreatitis in Children With Acute Lymphoblastic Leukemia After Chemotherapy

  2009cited by this paper
• Acute Pancreatitis in Children With Acute Lymphoblastic Leukemia Treated With L-Asparaginase

  2009cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

  2008cited by this paper
• Predicting asparaginase‐associated pancreatitis

  2007cited by this paper
• Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols.

  2007cited by this paper
• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies

  2007cited by this paper
• A modified CT severity index for evaluating acute pancreatitis: improved correlation with patient outcome.

  2004cited by this paper
• Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

  2001cited by this paper
• Complications of diagnostic and therapeutic ERCP: a prospective multicenter study

  2001cited by this paper
• Pegaspargase-induced pancreatitis.

  2000cited by this paper
• Early detection of chemotherapy‐related pancreatic enlargement in children using abdominal sonography. A preliminary report

  1976cited by this paper
• L-asparaginase in the treatment of neoplastic diseases in children.

  1971cited by this paper

• A Multicenter Study of Acute Abdomen in Children With Acute Lymphoblastic Leukemia: CCCG‐ALL‐2015

  2025cites this paper
• Pankreatitis durch Medikamente – Medikamente zur Behandlung der Pankreatitis

  2025cites this paper
• Recognition, prevention, and management of adverse events associated with asparaginase/ pegaspargase treatment of acute lymphoblastic leukemia in adults: consensus of an expert panel

  2025cites this paper
• Risk factors and outcomes of asparaginase-associated pancreatitis in pediatric patients with ALL.

  2025cites this paper
• International Association of Pancreatology Revised Guidelines on Acute Pancreatitis 2025.

  2025cites this paper
• Risk factors and outcome of asparaginase-associated pancreatitis in pediatric acute lymphoblastic leukemia

  2025cites this paper
• Screening of Amino Acids as a Safe Energy Source for Isolated Rat Pancreatic Acini

  2024cites this paper
• Risk factors and a prediction model of severe asparaginase-associated pancreatitis in children

  2024cites this paper
• A systems approach points to a therapeutic role for retinoids in asparaginase-associated pancreatitis

  2023cites this paper
• Efficacy and safety of endoscopic retrograde cholangiopancreatography in recurrent pancreatitis of pediatric asparaginase-associated pancreatitis

  2023cites this paper
• Asparaginase-associated Pancreatitis Complicated by Pancreatic Fluid Collection Treated with Endoscopic Cistogastrostomy in Pediatric Acute Lymphoblastic Leukemia: A Case Report and Systematic Review of the Literature.

  2023cites this paper
• Management of adult acute lymphoblastic leukemia in the Gulf Cooperation Council (GCC) countries: A consensus report from the GCC Adult ALL Working Group

  2023cites this paper
• Prediabetes and Associated Risk of Cardiovascular Events and Chronic Kidney Disease Among Adult Survivors of Childhood Cancer in the St Jude Lifetime Cohort

  2023cites this paper
• Pediatric Drug-Associated Pancreatitis Reveals Concomitant Risk Factors and Poor Reliability of Causality Scoring: Report From INSPPIRE

  2023cites this paper
• PEG-asparaginase treatment regimens for acute lymphoblastic leukaemia in children: a network meta-analysis.

  2023cites this paper
• Clinical summary of pediatric acute lymphoblastic leukemia patients complicated with asparaginase-associated pancreatitis in SCCLG-ALL-2016 protocol

  2023cites this paper
• Asparaginase: How to Better Manage Toxicities in Adults

  2022cites this paper
• Case Report: Genetic Analysis of PEG-Asparaginase Induced Severe Hypertriglyceridemia in an Adult With Acute Lymphoblastic Leukaemia

  2022cites this paper
• Diabetic ketoacidosis and pancreatitis secondary to peg-asparaginase

  2022cites this paper
• Asparaginase-associated pancreatitis in chemotherapy-treated pediatric patients: a five-year retrospective study.

  2022cites this paper
• Asparaginase in the Treatment of Acute Lymphoblastic Leukemia in Adults: Current Evidence and Place in Therapy

  2022cites this paper
• BLCTT_A_342052 55..79

  2022cites this paper
• Clinical analysis of asparaginase-associated pancreatitis in children.

  2022cites this paper
• Clinical insights into drug-associated pancreatic injury

  2022cites this paper
• SOHO State of the Art Updates and Next Questions | Asparaginase-Understanding and Overcoming Toxicities in Adults with ALL.

  2022cites this paper
• Pancreatitis aguda asociada a errores de dosificación de L-asparaginasa en pacientes pediátricos con leucemia linfoblástica aguda en terapia de inducción: estudio exploratorio

  2022cites this paper
• Asparaginase enzyme activity levels and toxicity in childhood acute lymphoblastic leukemia: a NOPHO ALL2008 study

  2021cites this paper
• Cetoacidose diabética e pancreatite secundárias à peg-asparaginase.

  2021cites this paper
• Children With Asparaginase-associated Pancreatitis Present Elevated Levels of Insulin, Total Cholesterol, and HOMA-IR Before Starting Acute Lymphoblastic Leukemia Treatment

  2021cites this paper
• Clinical Characteristics and Short-Term Outcomes of Children With Asparaginase-Associated Pancreatitis

  2021cites this paper
• SOHO State of the Art Updates and Next Questions: Management of Asparaginase Toxicity in Adolescents and Young Adults with Acute Lymphoblastic Leukemia.

  2021cites this paper
• Asparaginase: Understanding and Overcoming Toxicities

  2021cites this paper
• Asparaginase-Associated Pancreatitis in Pediatric Patients with Acute Lymphoblastic Leukemia: Current Perspectives

  2021cites this paper
• Demographics and risk factors for pediatric recurrent acute pancreatitis

  2021cites this paper
• Acute pancreatitis in children: a review with clinical perspectives to enhance imaging interpretation

  2021cites this paper
• Pegaspargase in Practice: Minimizing Toxicity, Maximizing Benefit

  2021cites this paper
• Pancréatite médicamenteuse

  2020cites this paper
• How I Treat the Toxicities of Pegasparaginase in Adults with Acute Lymphoblastic Leukemia.

  2020cites this paper
• Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln With Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients

  2020cites this paper
• Treatment outcome classification of pediatric Acute Lymphoblastic Leukemia patients with clinical and medical data using machine learning: A case study at MAHAK hospital

  2020cites this paper
• Drug-Induced Pancreatic Injury (DIPI): Redefining Drug-Induced Pancreatitis in Adult and Pediatric Populations

  2020cites this paper
• RETRACTED: Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study

  2020cites this paper
• The role of asparagine synthetase on nutrient metabolism in pancreatic disease.

  2020cites this paper
• Concurrent diabetic ketoacidosis and pancreatitis in Paediatric acute lymphoblastic leukemia receiving L-asparaginase

  2020cites this paper
• Association of asparaginase-associated pancreatitis and ULK2 gene polymorphism.

  2020cites this paper
• Diagnosis and Treatment-Related Complications of Acute Leukemia

  2019cites this paper
• Asparagine Synthetase Is Highly Expressed at Baseline in the Pancreas Through Heightened PERK Signaling

  2019cites this paper
• Immune thrombocytopenic purpura increased risk of subsequent pancreatitis: A Nationwide population cohort study

  2019cites this paper
• Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient

  2019cites this paper
• Crisis management in the treatment of childhood acute lymphoblastic leukemia: putting right what can go wrong (emergency complications of disease and treatment).

  2017cites this paper
• RETRACTED: Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study

  year unknowncites this paper